Palantir 's Q2 2025 $PLTR ( ▼ 1.14% ) results and strategic positioning provide compelling counterarguments to Citron Research's $40 price target. The company achieved its first $1 billion quarterly revenue with accelerating growth across all segments, demonstrating execution that fundamentally challenges Citron's core assumptions about the business model, competitive position, and valuation framework.